Federal Procurement Forecast
Purchase of an Illumina MiSeq i100 plus
Forecast overview
- Subagency
- FDA
- NAICS
- 541990
- Program office
- HFP ACQUISITION
Purchase of Illumina MiSeq i100 plus which has the increased capability of sequencing pathogrens detected in seafood. This purchase is in support of our culture independent pathogen identification program and is needed for rapid long read sequencing methods development to support screening for pathogens in field environmental samples in real-time
Related federal terms
- NAICS — North American Industry Classification System
Acquisition timeline
- Last verified on RFPCapture
- 2026-08-31
- Estimated solicitation
- 3/2026 (agency estimate)
- Estimated award
- 5/2026 (agency estimate)
- Expected period of performance end
- 5/2026 (agency estimate)
Why watch this
- This forecast is tied to an agency with active procurement in this NAICS.
- Recent awards exist in this market.
- Recompete context: Related award history found; treat as related public awards unless SAM.gov confirms a recompete.
Market context
- NAICS market
- NAICS 541990
- Active contractors in this market
- 5 with relevant federal experience
- Recent comparable awards
- 8 from public USAspending records
- Reported awardee
- AMERICA'S BLOOD CENTERS
- Agency spending trend
- $238.6M · Declining
Contractors with relevant federal experience
Action links
Track this forecast in CaptureIQ
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31